{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:19:34Z","timestamp":1788808774111,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003107","name":"German Federal Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.lanepe.2021.100128","type":"journal-article","created":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T18:22:12Z","timestamp":1622917332000},"page":"100128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Seroprevalence of Measles-, Mumps-, and Rubella-specific antibodies in the German adult population \u2013 cross-sectional analysis of the German Health Interview and Examination Survey for Adults (DEGS1)"],"prefix":"10.1016","volume":"7","author":[{"given":"Nicole","family":"Friedrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Poethko-M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Kuhnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Matysiak-Klose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Wichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Santibanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Mankertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanepe.2021.100128_bib0001","series-title":"Measles","year":"2019"},{"issue":"11","key":"10.1016\/j.lanepe.2021.100128_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-021465","article-title":"Impact and longevity of measles-associated immune suppression: a matched cohort study using data from the THIN general practice database in the UK","volume":"8","author":"Gadroen","year":"2018","journal-title":"BMJ Open"},{"issue":"10111","key":"10.1016\/j.lanepe.2021.100128_bib0003","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/S0140-6736(17)31463-0","article-title":"Measles","volume":"390","author":"Moss","year":"2017","journal-title":"Lancet"},{"issue":"9616","key":"10.1016\/j.lanepe.2021.100128_bib0004","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(08)60419-5","article-title":"Mumps","volume":"371","author":"Hviid","year":"2008","journal-title":"Lancet"},{"issue":"9984","key":"10.1016\/j.lanepe.2021.100128_bib0005","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/S0140-6736(14)60539-0","article-title":"Rubella","volume":"385","author":"Lambert","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.lanepe.2021.100128_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149160","article-title":"Using seroprevalence and immunisation coverage data to estimate the global burden of congenital rubella syndrome, 1996-2010: a systematic review","volume":"11","author":"Vynnycky","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.lanepe.2021.100128_bib0007","series-title":"Global measles and rubella strategic plan 2012-2020","year":"2012"},{"key":"10.1016\/j.lanepe.2021.100128_bib0008","unstructured":"WHO. Feasibility assessment of measles and rubella eradication. 2019.https:\/\/www.who.int\/immunization\/sage\/meetings\/2019\/october\/Feasibility_Assessment_of_Measles_and_Rubella_Eradication_final.pdf"},{"key":"10.1016\/j.lanepe.2021.100128_bib0009","series-title":"Masern-Schutzimpfung. Vademekum f\u00fcr Impf\u00e4rzte","first-page":"105","author":"Dittmann","year":"1980"},{"key":"10.1016\/j.lanepe.2021.100128_bib0010","series-title":"Masern-Schutzimpfung. Vademekum f\u00fcr Impf\u00e4rzte","first-page":"93","author":"Dittmann","year":"1986"},{"key":"10.1016\/j.lanepe.2021.100128_bib0011","series-title":"STIKO-Empfehlung zur Masernschutzimpfung","year":"1974"},{"key":"10.1016\/j.lanepe.2021.100128_bib0012","series-title":"STIKO-Empfehlungen 1976","year":"1976"},{"key":"10.1016\/j.lanepe.2021.100128_bib0013","series-title":"Erg\u00e4nzung der STIKO-Empfehlungen 1980","year":"1981"},{"key":"10.1016\/j.lanepe.2021.100128_bib0014","series-title":"STIKO-Empfehlungen 1991","year":"1991"},{"key":"10.1016\/j.lanepe.2021.100128_bib0015","series-title":"Empfehlungen der St\u00e4ndigen Impfkommission beim Robert Koch-Institut 2020\/2021","year":"2020"},{"key":"10.1016\/j.lanepe.2021.100128_bib0016","series-title":"Neuerungen in den Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am RKI f\u00fcr 2017\/2018","year":"2017"},{"issue":"6","key":"10.1016\/j.lanepe.2021.100128_bib0017","first-page":"148","article-title":"Gesetz f\u00fcr den Schutz vor Masern und zur St\u00e4rkung der Impfpr\u00e4vention (Masernschutzgesetz)","volume":"I","year":"2020","journal-title":"Bundesgesetzblatt"},{"key":"10.1016\/j.lanepe.2021.100128_bib0018","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1186\/1471-2458-12-730","article-title":"German health interview and examination survey for adults (DEGS) - design, objectives and implementation of the first data collection wave","volume":"12","author":"Scheidt-Nave","year":"2012","journal-title":"BMC Public Health"},{"issue":"5\u20136","key":"10.1016\/j.lanepe.2021.100128_bib0019","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s00103-012-1650-9","article-title":"[The first wave of the German Health Interview and Examination Survey for Adults (DEGS1): sample design, response, weighting and representativeness]","volume":"56","author":"Kamtsiuris","year":"2013","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"6\u20137","key":"10.1016\/j.lanepe.2021.100128_bib0020","first-page":"775","article-title":"[DEGS: German Health Interview and Examination Survey for Adults. A nationwide cross-sectional and longitudinal study within the framework of health monitoring conducted by the Robert Koch Institute]","volume":"55","author":"Gosswald","year":"2012","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100128_bib0021","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00103-012-1583-3","article-title":"[Measurement of the socioeconomic status within the German Health Update 2009 (GEDA)]","volume":"56","author":"Lampert","year":"2013","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"12","key":"10.1016\/j.lanepe.2021.100128_bib0022","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"issue":"45","key":"10.1016\/j.lanepe.2021.100128_bib0023","doi-asserted-by":"crossref","first-page":"7949","DOI":"10.1016\/j.vaccine.2011.08.081","article-title":"Sero-epidemiology of measles-specific IgG antibodies and predictive factors for low or missing titres in a German population-based cross-sectional study in children and adolescents (KiGGS)","volume":"29","author":"Poethko-Muller","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.lanepe.2021.100128_bib0024","series-title":"Bedeutung der biologischen Stabilitaet des Masern-Lebend-Impfstoffes im Hinblick auf Festlegungen zur Masernbekaempfung in der MVR","author":"Ganbaatar","year":"1985"},{"issue":"5\u20136","key":"10.1016\/j.lanepe.2021.100128_bib0025","first-page":"845","article-title":"[Vaccination coverage in German adults: results of the German Health Interview and Examination Survey for Adults (DEGS1)]","volume":"56","author":"Poethko-Muller","year":"2013","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"8","key":"10.1016\/j.lanepe.2021.100128_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/v11080765","article-title":"Measles Elimination: identifying Susceptible Sub-Populations to Tailor Immunization Strategies","volume":"11","author":"Kreidl","year":"2019","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.lanepe.2021.100128_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216219","article-title":"Sero-epidemiological study in prediction of the risk groups for measles outbreaks in Vojvodina, Serbia","volume":"14","author":"Ristic","year":"2019","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100128_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170257","article-title":"Decreasing seroprevalence of measles antibodies after vaccination - possible gap in measles protection in adults in the Czech Republic","volume":"12","author":"Smetana","year":"2017","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.lanepe.2021.100128_bib0029","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1017\/S0950268813001532","article-title":"High risk of a large measles outbreak despite 30 years of measles vaccination in The Netherlands","volume":"142","author":"Mollema","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.lanepe.2021.100128_bib0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13104-015-1109-9","article-title":"Vaccine storage and cold chain monitoring in the North West region of Cameroon: a cross sectional study","volume":"8","author":"Yakum","year":"2015","journal-title":"BMC Res Notes"},{"issue":"16","key":"10.1016\/j.lanepe.2021.100128_bib0031","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.vaccine.2007.01.020","article-title":"HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design","volume":"25","author":"Ovsyannikova","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.lanepe.2021.100128_bib0032","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S1473-3099(20)30442-4","article-title":"Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis","volume":"21","author":"Schenk","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"36","key":"10.1016\/j.lanepe.2021.100128_bib0033","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1016\/j.vaccine.2019.07.049","article-title":"Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: a 10-year follow-up","volume":"37","author":"Carryn","year":"2019","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.lanepe.2021.100128_bib0034","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.vaccine.2017.12.075","article-title":"Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine","volume":"36","author":"Seagle","year":"2018","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.lanepe.2021.100128_bib0035","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/infdis\/jis568","article-title":"Waning antibody levels and avidity: implications for MMR vaccine-induced protection","volume":"206","author":"Kontio","year":"2012","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.lanepe.2021.100128_bib0036","doi-asserted-by":"crossref","first-page":"e42867","DOI":"10.1371\/journal.pone.0042867","article-title":"Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity","volume":"7","author":"Poethko-Muller","year":"2012","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.lanepe.2021.100128_bib0037","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanepe.2021.100128_bib0038","unstructured":"STIKO. 95. Sitzung der St\u00e4ndigen Impfkommission (STIKO)2020. https:\/\/www.rki.de\/DE\/Content\/Kommissionen\/STIKO\/Protokolle\/protokolle_node.html"},{"issue":"16","key":"10.1016\/j.lanepe.2021.100128_bib0039","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.16.19182-en","article-title":"Mumps epidemiology in the mid-west of Ireland 2004-2008: increasing disease burden in the university\/college setting","volume":"14","author":"Whyte","year":"2009","journal-title":"Euro Surveill"},{"issue":"4","key":"10.1016\/j.lanepe.2021.100128_bib0040","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1086\/520028","article-title":"Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines","volume":"45","author":"Peltola","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.lanepe.2021.100128_bib0041","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ijmm.2015.08.011","article-title":"Laboratory-based investigation of suspected mumps cases submitted to the German National Reference Centre for Measles, Mumps, and Rubella, 2008 to 2013","volume":"305","author":"Mankertz","year":"2015","journal-title":"Int J Med Microbiol"},{"issue":"3","key":"10.1016\/j.lanepe.2021.100128_bib0042","doi-asserted-by":"crossref","first-page":"e58234","DOI":"10.1371\/journal.pone.0058234","article-title":"Seroprevalence of mumps in The Netherlands: dynamics over a decade with high vaccination coverage and recent outbreaks","volume":"8","author":"Smits","year":"2013","journal-title":"PLoS ONE"},{"issue":"16","key":"10.1016\/j.lanepe.2021.100128_bib0043","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.16.18838-en","article-title":"An ongoing multi-state outbreak of measles linked to non-immune anthroposophic communities in Austria, Germany, and Norway, March-April 2008","volume":"13","author":"Schmid","year":"2008","journal-title":"Euro Surveill"},{"issue":"6","key":"10.1016\/j.lanepe.2021.100128_bib0044","first-page":"902","article-title":"A third dose of measles-mumps-rubella vaccine to improve immunity against mumps in young adults","volume":"221","author":"Kaaijk","year":"2020","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100128_bib0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.15585\/mmwr.mm6701a7","article-title":"Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak","volume":"67","author":"Marin","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5\u20136","key":"10.1016\/j.lanepe.2021.100128_bib0046","first-page":"851","article-title":"[Vaccination coverage and predictors for vaccination level. Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)]","volume":"50","author":"Poethko-Muller","year":"2007","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1016\/j.lanepe.2021.100128_bib0047","series-title":"Impfempfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut \/Stand: M\u00e4rz 1998","year":"1998"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100128_bib0048","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227413","article-title":"Seroepidemiological study of rubella in Vojvodina, Serbia: 24 years after the introduction of the MMR vaccine in the national immunization programme","volume":"15","author":"Patic","year":"2020","journal-title":"PLoS ONE"},{"issue":"16","key":"10.1016\/j.lanepe.2021.100128_bib0049","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.vaccine.2014.01.066","article-title":"Seroprevalence of rubella antibodies in The Netherlands after 32 years of high vaccination coverage","volume":"32","author":"Smits","year":"2014","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.lanepe.2021.100128_bib0050","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1017\/S0950268810001536","article-title":"Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium","volume":"139","author":"Theeten","year":"2011","journal-title":"Epidemiol Infect"},{"issue":"4","key":"10.1016\/j.lanepe.2021.100128_bib0051","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1017\/S0950268806007400","article-title":"Rubella seroprofile of the Italian population: an 8-year comparison","volume":"135","author":"Rota","year":"2007","journal-title":"Epidemiol Infect"},{"issue":"32\u201333","key":"10.1016\/j.lanepe.2021.100128_bib0052","first-page":"306","article-title":"Bericht des Nationalen Referenzzentrums f\u00fcr Masern, Mumps, R\u00f6teln f\u00fcr die Jahre 2017 und 2018","author":"Mankertz","year":"2019","journal-title":"Epidemiologisches Bull"},{"key":"10.1016\/j.lanepe.2021.100128_bib0053","article-title":"A report on the epidemiology of selected vaccine-preventable diseases in the European Region","year":"2021","journal-title":"EpiBrief"},{"issue":"6","key":"10.1016\/j.lanepe.2021.100128_bib0054","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s15010-016-0926-7","article-title":"Measles, mumps, rubella, and varicella seroprevalence in refugees in Germany in 2015","volume":"44","author":"Jablonka","year":"2016","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100128_bib0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00103-003-0689-z","article-title":"[Antibodies against vaccine-preventable diseases in pregnant women and their offspring. Measles, mumps, rubella, poliomyelitis, and varicella]","volume":"47","author":"Sauerbrei","year":"2004","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100128_bib0056","article-title":"Seroprevalence to Measles Virus after Vaccination or Natural Infection in an Adult Population, in Italy","volume":"8","author":"Anichini","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"10.1016\/j.lanepe.2021.100128_bib0057","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jiph.2015.01.012","article-title":"Seroprevalence of measles and rubella virus antibodies in the population of the Community of Madrid, 2008-2009","volume":"8","author":"Garcia-Comas","year":"2015","journal-title":"J Infect Public Health"},{"issue":"9\u201310","key":"10.1016\/j.lanepe.2021.100128_bib0058","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0264-410X(99)00348-5","article-title":"Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage","volume":"18","author":"van den Hof","year":"1999","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.lanepe.2021.100128_bib0059","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/oxfordjournals.aje.a112633","article-title":"Differences between respondents and non-respondents in a population-based cardiovascular disease study","volume":"108","author":"Criqui","year":"1978","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.lanepe.2021.100128_bib0060","first-page":"533","article-title":"[Participation of people with migration background in health surveys of the Robert Koch Institute]","volume":"58","author":"Sass","year":"2015","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1016\/j.lanepe.2021.100128_bib0061","series-title":"Bev\u00f6lkerungsforschung Aktuell","first-page":"3","article-title":"Binnenwanderung in Deutschland seit 1991","volume":"2","author":"Stawarz","year":"2020"},{"issue":"2","key":"10.1016\/j.lanepe.2021.100128_bib0062","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jviromet.2005.08.001","article-title":"Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay","volume":"131","author":"Cohen","year":"2006","journal-title":"J Virol Methods"},{"issue":"6","key":"10.1016\/j.lanepe.2021.100128_bib0063","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1086\/521029","article-title":"Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination","volume":"196","author":"Jokinen","year":"2007","journal-title":"J Infect Dis"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776221001058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776221001058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T04:46:09Z","timestamp":1763009169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776221001058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":63,"alternative-id":["S2666776221001058"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2021.100128","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroprevalence of Measles-, Mumps-, and Rubella-specific antibodies in the German adult population \u2013 cross-sectional analysis of the German Health Interview and Examination Survey for Adults (DEGS1)","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2021.100128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100128"}}